| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative [+] | 7.7 | 6.3 | 5.4 | 3.9 | 1.3 |
| General and administrative | 7.7 | 6.3 | 5.4 | 3.9 | 1.3 |
| Research and development | 6.6 | 4.3 | 2.6 | 1.7 | 0.5 |
| Other operating expenses | | | | | -1.8 |
| EBITDA [+] | -14.3 | -10.6 | -8.0 | -5.6 | |
| EBITDA growth | 35.3% | 31.5% | 42.1% | | |
| Depreciation and amortization | 0.0 | 0.0 | 0.0 | 0.0 | |
| EBIT [+] | -14.3 | -10.6 | -8.0 | -5.7 | 0.0 |
| EBIT growth | 35.3% | 31.5% | 42.2% | | |
| Interest expense | 0.0 | 2.4 | 0.7 | | |
| Interest expense | 0.0 | 2.4 | 0.7 | | |
| Other income (expense), net [+] | -2.9 | -5.2 | -0.8 | | -1.8 |
| Gain (loss) on debt retirement | -1.8 | -1.4 | | | |
| Change in fair value of warrants | | -0.1 | 1.9 | | |
| Write-off of deferred debt issuance costs | -0.6 | -0.6 | | | |
| Other | -3.0 | -7.6 | -1.5 | | |
| Pre-tax income | -17.3 | -18.2 | -9.5 | -5.7 | -1.8 |
| Income taxes | -0.8 | -0.2 | 0.0 | 0.0 | 0.0 |
| Tax rate | 4.7% | 1.1% | 0.0% | 0.0% | 0.0% |
| Minority interest | -0.8 | -0.2 | | | |
| Net income | -16.7 | -18.8 | -10.4 | -5.7 | -1.8 |
| |
| Basic EPS [+] | ($0.55) | ($0.84) | ($0.77) | ($0.44) | ($0.16) |
| Growth | -34.2% | 9.3% | 76.9% | 176.5% | |
| Diluted EPS [+] | ($0.55) | ($0.84) | ($0.77) | ($0.44) | ($0.16) |
| Growth | -34.2% | 9.3% | 76.9% | 176.5% | |
| |
| Shares outstanding (basic) [+] | 30.2 | 22.3 | 13.5 | 13.0 | 11.3 |
| Growth | 35.6% | 65.1% | 4.0% | 15.0% | |
| Shares outstanding (diluted) [+] | 30.2 | 22.3 | 13.5 | 13.0 | 11.3 |
| Growth | 35.6% | 65.1% | 4.0% | 15.0% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |